195 related articles for article (PubMed ID: 29044160)
1. Eosinophilia and clinical outcome of chronic obstructive pulmonary disease: a meta-analysis.
Ho J; He W; Chan MTV; Tse G; Liu T; Wong SH; Leung CCH; Wong WT; Tsang S; Zhang L; Chan RYP; Gin T; Leung J; Lau BWM; Wu WKK; Ngai SPC
Sci Rep; 2017 Oct; 7(1):13451. PubMed ID: 29044160
[TBL] [Abstract][Full Text] [Related]
2. Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD.
Gao J; Zhang M; Zhou L; Yang X; Wu H; Zhang J; Wu F
Int J Chron Obstruct Pulmon Dis; 2017; 12():1287-1293. PubMed ID: 28490872
[TBL] [Abstract][Full Text] [Related]
3. The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.
Kang HS; Kim SK; Kim YH; Kim JW; Lee SH; Yoon HK; Rhee CK
BMC Pulm Med; 2021 Mar; 21(1):74. PubMed ID: 33653314
[TBL] [Abstract][Full Text] [Related]
4. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
5. Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.
Negewo NA; McDonald VM; Baines KJ; Wark PA; Simpson JL; Jones PW; Gibson PG
Int J Chron Obstruct Pulmon Dis; 2016; 11():1495-504. PubMed ID: 27445469
[TBL] [Abstract][Full Text] [Related]
6. Blood Eosinophilia and Its Stability in Hospitalized COPD Exacerbations are Associated with Lower Risk of All-Cause Mortality.
Zhang Y; Liang LR; Zhang S; Lu Y; Chen YY; Shi HZ; Lin YX
Int J Chron Obstruct Pulmon Dis; 2020; 15():1123-1134. PubMed ID: 32547000
[TBL] [Abstract][Full Text] [Related]
7. Eosinophils in COPD Exacerbations Are Associated With Increased Readmissions.
Couillard S; Larivée P; Courteau J; Vanasse A
Chest; 2017 Feb; 151(2):366-373. PubMed ID: 27746201
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD.
Kang HS; Rhee CK; Kim SK; Kim JW; Lee SH; Yoon HK; Ahn JH; Kim YH
Int J Chron Obstruct Pulmon Dis; 2016; 11():2467-2473. PubMed ID: 27757029
[TBL] [Abstract][Full Text] [Related]
9. Blood Eosinophils and Clinical Outcome of Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-Analysis.
You Y; Shi GC
Respiration; 2021; 100(3):228-237. PubMed ID: 33373986
[TBL] [Abstract][Full Text] [Related]
10. Blood eosinophils and treatment response in hospitalized exacerbations of chronic obstructive pulmonary disease: A case-control study.
Serafino-Agrusa L; Scichilone N; Spatafora M; Battaglia S
Pulm Pharmacol Ther; 2016 Apr; 37():89-94. PubMed ID: 26996272
[TBL] [Abstract][Full Text] [Related]
11. Blood eosinophilia as a marker of early and late treatment failure in severe acute exacerbations of COPD.
Prins HJ; Duijkers R; Lutter R; Daniels JM; van der Valk P; Schoorl M; Kerstjens HA; van der Werf TS; Boersma WG
Respir Med; 2017 Oct; 131():118-124. PubMed ID: 28947018
[TBL] [Abstract][Full Text] [Related]
12. Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
Kiani A; Rahimi F; Afaghi S; Paat M; Varharam M; Dizaji MK; Dastoorpoor M; Abedini A
Can Respir J; 2023; 2023():8678702. PubMed ID: 37153722
[TBL] [Abstract][Full Text] [Related]
13. Does eosinophilic COPD exacerbation have a better patient outcome than non-eosinophilic in the intensive care unit?
Saltürk C; Karakurt Z; Adiguzel N; Kargin F; Sari R; Celik ME; Takir HB; Tuncay E; Sogukpinar O; Ciftaslan N; Mocin O; Gungor G; Oztas S
Int J Chron Obstruct Pulmon Dis; 2015; 10():1837-46. PubMed ID: 26392758
[TBL] [Abstract][Full Text] [Related]
14. Eosinophils and chronic obstructive pulmonary diseases (COPD) in hospitalized COVID-19 patients.
Fekri MS; Najminejad Z; Karami Robati F; Dalfardi B; Lashkarizadeh M; Najafzadeh MJ
BMC Infect Dis; 2024 Jun; 24(1):553. PubMed ID: 38831292
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for respiratory hospitalizations in a population of patients with a clinical diagnosis of COPD.
Veljanovski J; Ouellette DR
Int J Chron Obstruct Pulmon Dis; 2018; 13():1061-1069. PubMed ID: 29681729
[TBL] [Abstract][Full Text] [Related]
16. Antibiotics for exacerbations of chronic obstructive pulmonary disease.
Vollenweider DJ; Jarrett H; Steurer-Stey CA; Garcia-Aymerich J; Puhan MA
Cochrane Database Syst Rev; 2012 Dec; 12():CD010257. PubMed ID: 23235687
[TBL] [Abstract][Full Text] [Related]
17. A GATA3-specific DNAzyme attenuates sputum eosinophilia in eosinophilic COPD patients: a feasibility randomized clinical trial.
Greulich T; Hohlfeld JM; Neuser P; Lueer K; Klemmer A; Schade-Brittinger C; Harnisch S; Garn H; Renz H; Homburg U; Renz J; Kirsten A; Pedersen F; Müller M; Vogelmeier CF; Watz H
Respir Res; 2018 Apr; 19(1):55. PubMed ID: 29615049
[TBL] [Abstract][Full Text] [Related]
18. Sputum eosinophilia and the short term response to inhaled mometasone in chronic obstructive pulmonary disease.
Brightling CE; McKenna S; Hargadon B; Birring S; Green R; Siva R; Berry M; Parker D; Monteiro W; Pavord ID; Bradding P
Thorax; 2005 Mar; 60(3):193-8. PubMed ID: 15741434
[TBL] [Abstract][Full Text] [Related]
19. Demographic and Clinical Characteristics of COPD Patients at Different Blood Eosinophil Levels in the UK Clinical Practice Research Datalink.
Landis S; Suruki R; Maskell J; Bonar K; Hilton E; Compton C
COPD; 2018 Apr; 15(2):177-184. PubMed ID: 29558236
[TBL] [Abstract][Full Text] [Related]
20. Post-bronchodilator Reversibility of FEV
Chou KT; Su KC; Hsiao YH; Huang SF; Ko HK; Tseng CM; Su VY; Perng DW
Arch Bronconeumol; 2017 Oct; 53(10):547-553. PubMed ID: 28438346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
